Brain cancer gene therapy trial pulled before it began
NCT ID NCT04105374
First seen May 16, 2026 · Last updated May 24, 2026 · Updated 2 times
Summary
This study aimed to test whether adding a special virus (Toca 511) and a fungus-fighting drug (Toca FC) to standard chemotherapy and radiation could help people with newly diagnosed glioblastoma, an aggressive brain cancer. The virus was designed to make cancer cells convert the drug into a cancer-killer. However, the trial was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPLASTIC ASTROCYTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.